Utility of GPT-4 as an Informational Patient Resource in Otolaryngology

Abstract

We sought to understand the potential utility of ChatGPT as an informational resource for otolaryngology patients. We evaluated responses by GPT-4 to queries based on the American Academy of Otolaryngology’s Clinical Practice Guidelines. We found that while otolaryngology advice provided by ChatGPT is generally safe, it lacks accuracy and comprehensiveness, limiting its utility as an informational resource for patients.

Lay Summary As the popularity of ChatGPT explodes, patients may turn to it for medical advice. We found that while otolaryngology advice provided by ChatGPT is generally safe, it lacks accuracy and comprehensiveness, limiting its utility as an informational resource for patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data is available in the Supplement.

留言 (0)

沒有登入
gif